Next DTP-22-018, GMP production of 40 MG z-endoxifen (NSC 774768) capsules contract/to#dctd-2022-1007 development & manufacture of oral & topical dosage forms - PRB
Ended Awarded Last action
- Contract number
- 75N91022F00004
- Awardee
-
Societal Cdmo San Diego, LLC UEI YRPTVKHDL7Z5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $149,535
Award facts
- Opportunity
-
- TORFPDCTD20221007 Solicitation number
- Contract value 100% obligated
- $149,535.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- Q517 Pharmacy Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | -$40,000 | |
| Original award | $189,535 |
About this award
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $149,535.00 Firm Fixed Price Delivery Order contract to Societal CDMO San Diego, LLC, a self-certified small disadvantaged business, for the GMP production of 40 mg z-endoxifen (NSC 774768) capsules. This Delivery Order contract is associated with the larger Drug Formulation and Manufacturing Contracts 2019 indefinite delivery contract vehicle. The contract supports the development and manufacture of oral and topical dosage forms for the National Cancer Institute's research programs. There was no set-aside used for this award, which has a completion date of March 31, 2024.
Quick answers
Who was awarded contract 75N91022F00004?
75N91022F00004 was awarded to Societal Cdmo San Diego, LLC by National Cancer Institute (National Institutes of Health) on June 27, 2022.
How much is contract 75N91022F00004 worth?
The government has obligated $149,535 on 75N91022F00004.
Is contract 75N91022F00004 an order under another contract?
Yes. 75N91022F00004 is a delivery order under 75N98019D00058, an indefinite delivery contract, on Drug Formulation and Manufacturing Contracts 2019.
Was contract 75N91022F00004 competed?
The extent of competition for 75N91022F00004 was full and open competition after exclusion of sources. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award